BMRN vs NEU · P/E 40, rev $1.76B vs P/E 15, rev $1.42B
Biomarin Pharmaceutical Inc (BMRN) versus NewMarket Corporation (NEU) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
NewMarket Corporation (NEU) is a specialty chemicals company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported NEU revenue for 2026-06-30 was $1.42B. Net income was $251.8M. NEU currently screens at market cap $6.96B and trailing P/E 14.7.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. NEU currently screens at market cap $6.96B and trailing P/E 14.7.
Not investment advice. Open the BMRN and NEU stock pages for the full models.
Not investment advice.